​

Funding Round

Series C - Iconic Therapeutics

Series C - Iconic Therapeutics

Investment Firm

Overview

Iconic Therapeutics develops and commercializes immunoconjugate proteins that trigger the immune system to destroy invader cells.

Announced Date

Jan 11, 2016

Closed on Date

Dec 24, 2015

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

6

Investor Name
Participant InvestorLundbeckfonden Ventures
Participant InvestorHBM Healthcare Investments
Participant InvestorMPM Capital
Participant InvestorH.I.G. Capital
Participant InvestorOUP (Osage University Partners)

Round Details and Background

Iconic Therapeutics raised $40000000 on 2016-01-11 in Series C

Iconic Therapeutics develops and commercializes immunoconjugate proteins that trigger the immune system to destroy invader cells.

Company Funding History

12

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 30, 2007
Venture Round - Iconic Therapeutics
1-1.3M
Aug 22, 2011
Venture Round - Iconic Therapeutics
1-undefined
Apr 16, 2014
Series B - Iconic Therapeutics
3-20.0M
Jan 17, 2009
Venture Round - Iconic Therapeutics
2-2.5M

Recent Activity

There is no recent news or activity for this profile.